SEC Issues Trading Suspension Order Involving Immune Pharmaceuticals
April 16, 2021
April 16, 2021
WASHINGTON, April 16 -- The Securities and Exchange Commission issued the following trading suspension order:
The Securities and Exchange Commission announced the temporary suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934, of trading in the securities of Immune Pharmaceuticals Inc. ("IMNPQ" or "the Company") (CIK No. 0001208261), of Fort Lee, New Jersey at 9:30 a.m. EDT on April 19, 2021, and terminating at 11:59 p.m. EDT on April 30, . . .
The Securities and Exchange Commission announced the temporary suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934, of trading in the securities of Immune Pharmaceuticals Inc. ("IMNPQ" or "the Company") (CIK No. 0001208261), of Fort Lee, New Jersey at 9:30 a.m. EDT on April 19, 2021, and terminating at 11:59 p.m. EDT on April 30, . . .